Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-07-30
Davies Scott M Files Illumina (ILMN) Form 4 - July 30, 2026
Davies Scott M sold 615 ILMN shares worth $123.0K in this Form 4 filing, reported to the SEC on 2026-07-30.
- Insider
- Davies Scott M
- Issuer
- Illumina, Inc. ILMN · NASDAQ
- Filed
- Period
- 2026-07-30
- Accession
- 0001110803-26-000161
- Source
- Official filing on sec.gov ↗
Transactions (1)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Davies Scott M | 2026-07-30 | Sell | 615 | $200.00 | $123.0K | Direct |
| Net change | −615 | −$123.0K | ||||
About Illumina, Inc.
Illumina, Inc. operates as a global leader in the life sciences industry, focusing on the development and manufacturing of integrated systems for the analysis of genetic variation and function. Primarily, Illumina’s products and services are pivotal in advancing genomic research, enabling scientists to explore DNA sequencing and genetic mapping with high precision and efficiency. The company’s solutions are extensively utilized in fields such as oncology, reproductive health, and genetic disease diagnostics. Known for its cutting-edge sequencing tools, Illumina plays a crucial role in driving innovation in personalized medicine, helping to tailor medical treatments to individual genetic profiles. Headquartered in San Diego, California, Illumina contributes significantly to the genomics sector’s expansion, supporting initiatives in health and medicine, agrigenomics, and microbiology. By providing critical tools for genetic analysis, Illumina aids researchers and clinical laboratories worldwide, influencing how healthcare is approached and offering insights into complex biological systems.
Track ILMN insider activity
Get alerted when Illumina, Inc. executives buy or sell their shares.